Established in 1997 as a single site operation, Probiotec Limited has a reputation for innovation and rapid response to market opportunities. Its growth has been fuelled by strong organic growth and strategic acquisitions along with relationships and joint ventures with global market participants that want to conduct business with a company that maintains high levels of quality and innovation.

Since beginning operations in 1997, Probiotec has quickly emerged as a leading manufacturer, marketer and distributor of a diverse, high quality range of prescription and over-the-counter (OTC) pharmaceuticals, complementary medicines and specialty ingredients.

Listed on the Australian Stock Exchange (ASX) since November 2006, our Australian owned and operated company has built an enviable reputation for developing innovative new pharmaceutical, nutraceutical and cosmeceutical products which not only address researched consumer needs, but also succeed in gaining the clinical approvals necessary to respond rapidly to market opportunities, both domestically and internationally.

What separates Probiotec from other trusted contract manufacturers is not only that we invest so heavily in Research and Development; equip our production facilities with the latest new technologies; employ chemists and microbiologists of the highest calibre and maintain Quality Assurance standards that are second to none, but we also manufacture and market our own products. As a result, we have a full understanding of the process and dynamics of developing formulations (and brands) for the retail market that deliver margins that optimise return-on-investment.

Our proven experience and expertise extends across a wide range of healthcare goods – offering you access to a cost-efficient contract manufacturer of existing Probiotec formulations, new custom developed formulations or formulations which you already possess and wish to produce in a wide range of categories.